Intero Biosystems wants drugmakers to test on mini human intestines, not animals
By Kate Park
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
Read it in your languageMachine translation by Google of the publisher's page
Explained in this story
Startup
A young company built to grow quickly, often around a new product or technology, usually funded by investors.
Startups create new jobs and industries, but most fail, which is why funding rounds are closely watched.
More about Startup
